Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-19T06:37:27.676Z Has data issue: false hasContentIssue false

Identification and characterization of a novel Neospora caninum immune mapped protein 1

Published online by Cambridge University Press:  12 March 2012

X. CUI
Affiliation:
Key Laboratory of Animal Epidemiology and Zoonosis, Ministry of Agriculture, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China
T. LEI
Affiliation:
Key Laboratory of Animal Epidemiology and Zoonosis, Ministry of Agriculture, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China
D. Y. YANG
Affiliation:
Key Laboratory of Animal Epidemiology and Zoonosis, Ministry of Agriculture, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China
P. HAO
Affiliation:
Key Laboratory of Animal Epidemiology and Zoonosis, Ministry of Agriculture, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China
Q. LIU*
Affiliation:
Key Laboratory of Animal Epidemiology and Zoonosis, Ministry of Agriculture, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China
*
*Corresponding author: Tel: +86 10 6273 4496. Fax: +86 10 6273 2804. E-mail: [email protected]

Summary

Immune mapped protein 1 (IMP1) is a newly discovered protein in Eimeria maxima. It is recognized as a potential vaccine candidate against E. maxima and a highly conserved protein in apicomplexan parasites. Although the Neospora caninum IMP1 (NcIMP1) orthologue of E. maxima IMP1 was predicted in the N. caninum genome, it was still not identified and characterized. In this study, cDNA sequence encoding NcIMP1 was cloned by RT-PCR from RNA isolated from Nc1 tachyzoites. NcIMP1 was encoded by an open reading frame of 1182 bp, which encoded a protein of 393 amino acids with a predicted molecular weight of 42·9 kDa. Sequence analysis showed that there was neither a signal peptide nor a transmembrane region present in the NcIMP1 amino acid sequence. However, several kinds of functional protein motifs, including an N-myristoylation site and a palmitoylation site were predicted. Recombinant NcIMP1 (rNcIMP1) was expressed in Escherichia coli and then purified rNcIMP1 was used to prepare specific antisera in mice. Mouse polyclonal antibodies raised against the rNcIMP1 recognized an approximate 43 kDa native IMP1 protein. Immunofluorescence analysis showed that NcIMP1 was localized on the membrane of N. caninum tachyzoites. The N-myristoylation site and the palmitoylation site were found to contribute to the localization of NcIMP1. Furthermore, the rNcIMP1-specific antibodies could inhibit cell invasion by N. caninum tachyzoites in vitro. All the results indicate that NcIMP1 is likely to be a membrane protein of N. caninum and may be involved in parasite invasion.

Type
Research Article
Copyright
Copyright © Cambridge University Press 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Baszler, T. V., Shkap, V., Mwangi, W., Davies, C. J., Mathison, B. A. and Mazuz, M. (2008). Bovine immune response to inoculation with Neospora caninum surface antigen SRS2 lipopeptides mimics immune response to infection with live parasites. Clinical and Vaccine Immunology 15, 659667.CrossRefGoogle ScholarPubMed
Bendtsen, J. D., Nielsen, H., Von-Heijne, G. and Brunak, S. (2004). Improved prediction of signal peptides: SignalP 3.0. Journal of Molecular Biology 340, 783795.CrossRefGoogle ScholarPubMed
Blake, D. P., Billington, K. J., Copestake, S. L., Oakes, R. D. and Quail, M. A. (2011). Genetic mapping identifies novel highly protective antigens for an apicomplexan parasite. PLoS Pathology 7, e1001279CrossRefGoogle ScholarPubMed
Cadwallader, K. A., Paterson, H., Macdonald, S. G. and Hancock, J. F. (1994). N-terminally myristoylated Ras proteins require palmitoylation or a polybasic domain for plasma membrane localization. Molecular and Cellular Biology 14, 47224730.Google ScholarPubMed
Cannas, A., Naguleswaran, A., Muller, N., Eperon, S., Gottstein, B. and Hemphill, A. (2003). Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines. Parasitology 126, 303312.CrossRefGoogle ScholarPubMed
Debache, K., Guionaud, C., Alaeddine, F., Mevissen, M. and Hemphill, A. (2008). Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites. International Journal for Parasitology 38, 14551463.CrossRefGoogle ScholarPubMed
Dubey, J. P. (1999). Neosporosis in cattle: biology and economic impact. Journal of the American Veterinary Medical Association 214, 11601163.CrossRefGoogle ScholarPubMed
Dubey, J. P., Hanel, A. L., Lindsay, D. S. and Topper, M. J. (1988). Neonatal Neospora caninum infection in dogs: isolation of the causative agent and experimental transmission. Journal of the American Veterinary Medical Association 193, 12591263.Google ScholarPubMed
Dubey, J. P. and Lindsay, D. S. (1996). A review of Neospora caninum and neosporosis. Veterinary Parasitology 67, 159.CrossRefGoogle ScholarPubMed
Dubey, J. P., Schares, G. and Ortega-Mora, L. M. (2007). Epidemiology and control of neosporosis and Neospora caninum. Clinical Microbiology Reviews 20, 323367.CrossRefGoogle ScholarPubMed
Ellis, J., Miller, C., Quinn, H., Ryce, C. and Reichel, M. (2008). Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model). Vaccine 26, 59895996.CrossRefGoogle ScholarPubMed
Haldorson, G. J., Stanton, J. B., Mathison, B. A., Suarez, C. E. and Baszler, T. V. (2006). Neospora caninum: Antibodies directed against tachyzoite surface protein NcSRS2 inhibit parasite attachment and invasion of placental trophoblasts in vitro. Experimental Parasitology 112, 72178.CrossRefGoogle ScholarPubMed
Hasler, B., Regula, G., Stark, K. D., Sager, H., Gottstein, B. and Reist, M. (2006 a). Financial analysis of various strategies for the control of Neospora caninum in dairy cattle in Switzerland. Preventive Veterinary Medicine 77, 230253.CrossRefGoogle ScholarPubMed
Hasler, B., Stark, K. D., Sager, H., Gottstein, B. and Reist, M. (2006 b). Simulating the impact of four control strategies on the population dynamics of Neospora caninum infection in Swiss dairy cattle. Preventive Veterinary Medicine 77, 254283.CrossRefGoogle ScholarPubMed
Hof, W. V. and Resh, M. D. (2000). Targeting proteins to plasma membrane and membrane microdomains by N-terminal myristoylation and palmitoylation. Methods in Enzymology 327, 317330.CrossRefGoogle Scholar
Liao, M., Xuan, X. N., Huang, X., Shirafuji, H., Fukumoto, S., Hirata, H. and Fujisaki, K. (2005). Identification and characterization of cross-reactive antigens from Neospora caninum and Toxoplasma gondii. Parasitology 30, 481488.CrossRefGoogle Scholar
Martinez, A., Traverso, J. A., Valot, B., Ferro, M., Espagne, C. and Ephritikhine, G. (2008). Extent of N-terminal modifications in cytosolic proteins from eukaryotes. Proteomics 8, 28092831.CrossRefGoogle ScholarPubMed
Maurer-Stroh, S., Eisenhaber, B. and Eisenhaber, F. (2002). N-terminal N-myristoylation of proteins: refinement of the sequence motif and its taxon-specific differences. Journal of Molecular Biology 317, 523540.CrossRefGoogle ScholarPubMed
Monney, T., Debache, K. and Hemphill, A. (2011). Vaccines against a major cause of abortion in cattle, Neospora caninum infection. Animals 1, 306325.CrossRefGoogle Scholar
Nishikawa, Y., Xuan, X., Nagasawa, H., Igarashi, I., Fujisaki, K. and Otsuka, H. (2000). Monoclonal antibody inhibition of Neospora caninum tachyzoite invasion into host cells. International Journal for Parasitology 30, 5158.CrossRefGoogle ScholarPubMed
Nishikawa, Y., Xuan, X., Nagasawa, H., Igarashi, I., Fujisaki, K. and Otsuka, H. (2001). Prevention of vertical transmission of Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying NcSRS2 gene. Vaccine 19, 17101716.CrossRefGoogle ScholarPubMed
Nishikawa, Y., Zhang, H. S., Ikehara, Y., Kojima, N., Xuan, X. N. and Yokoyama, N. (2009). Immunization with oligomannose-coated liposome-entrapped dense granule protein 7 protects dams and offspring from Neospora caninum infection in mice. Clinical and Vaccine Immunology 16, 792797.CrossRefGoogle ScholarPubMed
Peitzsch, R. M. and McLaughlin, S. (1993). Binding of acylated peptides and fatty acids to phospholipid vesicles: pertinence to myristoylated proteins. Biochemistry 32, 1043610443.CrossRefGoogle ScholarPubMed
Pinitkiatisakul, S., Friedman, M., Wikman, M., Mattsson, J. G. and Lundén, A. (2007). Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations. Vaccine 25, 36583668.CrossRefGoogle ScholarPubMed
Podell, S. and Gribskov, M. (2004). Predicting N-terminal myristoylation sites in plant proteins. BMC Genomics 5, 37.CrossRefGoogle ScholarPubMed
Ren, J., Wen, L. P., Gao, X. J., Jin, C. J., Xue, Y. and Yao, X. B. (2008). CSS-Palm 2.0: an updated software for palmitoylation sites prediction. Protein Engineering, Design and Selection 21, 639644.CrossRefGoogle ScholarPubMed
Resh, M. D. (1999). Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochimica et Biophysica Acta 1451, 116.CrossRefGoogle ScholarPubMed
Sibley, L. D., Messina, M. and Niesman, I. R. (1994). Stable DNA transformation in the obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan auxotrophy. Proceedings of the Nationall Academy of Sciences, USA 91, 55085512.CrossRefGoogle ScholarPubMed
Zha, J., Weiler, S., Oh, K. J., Wei, M. C. and Korsmeyer, S. J. (2000). Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 290, 17611765.CrossRefGoogle ScholarPubMed
Zhang, G. H., Huang, X. H., Boldbaatara, D., Battura, B., Battsetsega, B. and Zhang, H. S. (2010). Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice. Vaccine 28, 72437247.CrossRefGoogle ScholarPubMed
Zhang, H. S., Compaore, M. K. A., Lee, E., Liao, M., Zhang, G. H. and Xuan, X. X. (2007 a). Apical membrane antigen 1 is a cross-reactive antigen between Neospora caninum and Toxoplasma gondii, and the anti-NcAMA1 antibody inhibits host cell invasion by both parasites. Molecular and Biochemical Parasitology 151, 205212.CrossRefGoogle ScholarPubMed
Zhang, H. S., Lee, E., Liao, M., Compaore, M. K. A., Zhang, G. H. and Kawase, O. (2007 b). Identification of ribosomal phosphoprotein P0 of Neospora caninum as a potential common vaccine candidate for the control of both neosporosis and toxoplasmosis. Molecular and Biochemical Parasitology 153, 141148.CrossRefGoogle ScholarPubMed
Zhou, F., Xue, Y., Yao, X. and Xu, Y. (2006). CSS-Palm: palmitoylation site prediction with a clustering and scoring strategy (CSS). Bioinformatics 22, 894896.CrossRefGoogle ScholarPubMed